Fulgent Genetics Return on Tangible Equity 2015-2025 | FLGT
Current and historical return on tangible equity values for Fulgent Genetics (FLGT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Fulgent Genetics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.04B | $0.97B | -4.33% |
| 2024-12-31 | $-0.04B | $0.97B | -4.43% |
| 2024-09-30 | $-0.17B | $0.98B | -17.03% |
| 2024-06-30 | $-0.16B | $0.97B | -16.82% |
| 2024-03-31 | $-0.17B | $0.96B | -17.00% |
| 2023-12-31 | $-0.17B | $0.97B | -17.15% |
| 2023-09-30 | $-0.06B | $0.98B | -6.45% |
| 2023-06-30 | $-0.05B | $0.98B | -4.80% |
| 2023-03-31 | $-0.03B | $0.98B | -2.42% |
| 2022-12-31 | $0.14B | $0.98B | 13.16% |
| 2022-09-30 | $0.27B | $1.07B | 24.29% |
| 2022-06-30 | $0.39B | $1.10B | 36.01% |
| 2022-03-31 | $0.46B | $1.23B | 44.37% |
| 2021-12-31 | $0.51B | $1.08B | 54.46% |
| 2021-09-30 | $0.57B | $0.96B | 70.79% |
| 2021-06-30 | $0.49B | $0.89B | 80.69% |
| 2021-03-31 | $0.42B | $0.80B | 101.40% |
| 2020-12-31 | $0.21B | $0.57B | 92.64% |
| 2020-09-30 | $0.05B | $0.19B | 43.84% |
| 2020-06-30 | $0.00B | $0.09B | 2.61% |
| 2020-03-31 | $0.00B | $0.08B | -1.48% |
| 2019-12-31 | $0.00B | $0.08B | -1.67% |
| 2019-09-30 | $0.00B | $0.06B | -5.80% |
| 2019-06-30 | $-0.01B | $0.05B | -9.76% |
| 2019-03-31 | $-0.01B | $0.05B | -11.59% |
| 2018-12-31 | $-0.01B | $0.05B | -11.43% |
| 2018-09-30 | $-0.01B | $0.05B | -11.27% |
| 2018-06-30 | $-0.01B | $0.05B | -11.16% |
| 2018-03-31 | $-0.01B | $0.05B | -9.17% |
| 2017-12-31 | $0.00B | $0.05B | -5.45% |
| 2017-09-30 | $0.00B | $0.06B | 0.00% |
| 2017-06-30 | $0.00B | $0.06B | 0.00% |
| 2017-03-31 | $-0.01B | $0.06B | -13.51% |
| 2016-12-31 | $-0.01B | $0.05B | -25.81% |
| 2016-06-30 | $-0.01B | $0.02B | -109.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.618B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.989B | 58.51 |
| Hims & Hers Health (HIMS) | United States | $13.669B | 142.02 |
| Tempus AI (TEM) | United States | $11.962B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.646B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.825B | 59.77 |
| Hinge Health (HNGE) | United States | $3.100B | 0.00 |
| Privia Health (PRVA) | United States | $2.659B | 181.75 |
| Enovis (ENOV) | United States | $1.751B | 9.76 |
| Schrodinger (SDGR) | United States | $1.545B | 0.00 |
| Phreesia (PHR) | United States | $1.527B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Azenta (AZTA) | United States | $1.371B | 63.70 |
| 10x Genomics (TXG) | United States | $1.338B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Claritev (CTEV) | United States | $0.663B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 766.67 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.139B | 0.00 |
| Pulmonx (LUNG) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |